GE Healthcare has achieved a significant regulatory milestone with the FDA’s expansion of approval for its Vizamyl diagnostic tool, revolutionizing the diagnosis of Alzheimer’s disease.
GE Healthcare Inc is a leading provider of innovative medical technology, leveraging AI and cloud solutions to enhance patient care, diagnostics, and healthcare delivery.